Maze Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Maze Therapeutics, Inc. has filed 182 SEC EDGAR filings since 21 Jun 2024

SEC filing history

Showing 126-150 of 182 matching filings.

Per page
25
Current page
6
8-K File 001-42490

8-K

Filing date
31 Mar 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94841

SCHEDULE 13G filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94841

SCHEDULE 13G filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94841

SCHEDULE 13G filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94841

SCHEDULE 13G filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
06 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-284652

S-8

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-284164

424B4

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284164

EFFECT filing

Filing date
30 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-284612

S-1MEF

Filing date
30 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .